Breschi MC - Search Results

1

New benzopyran-based openers of the mitochondrial ATP-sensitive potassium channel with potent anti-ischemic properties.

Breschi MC, Calderone V, Martelli A, Minutolo F, Rapposelli S, Testai L, Tonelli F, Balsamo A. Breschi MC, et al. J Med Chem. 2006 Dec 28;49(26):7600-2. doi: 10.1021/jm061228l. J Med Chem. 2006. PMID: 17181142

2

NO-sartans: a new class of pharmacodynamic hybrids as cardiovascular drugs.

Breschi MC, Calderone V, Digiacomo M, Martelli A, Martinotti E, Minutolo F, Rapposelli S, Balsamo A. Breschi MC, et al. J Med Chem. 2004 Nov 4;47(23):5597-600. doi: 10.1021/jm049681p. J Med Chem. 2004. PMID: 15509155

3

New NO-releasing pharmacodynamic hybrids of losartan and its active metabolite: design, synthesis, and biopharmacological properties.

Breschi MC, Calderone V, Digiacomo M, Macchia M, Martelli A, Martinotti E, Minutolo F, Rapposelli S, Rossello A, Testai L, Balsamo A. Breschi MC, et al. J Med Chem. 2006 Apr 20;49(8):2628-39. doi: 10.1021/jm0600186. J Med Chem. 2006. PMID: 16610806

4

Spirocyclic benzopyran-based derivatives as new anti-ischemic activators of mitochondrial ATP-sensitive potassium channel.

Breschi MC, Calderone V, Digiacomo M, Manganaro M, Martelli A, Minutolo F, Rapposelli S, Testai L, Tonelli F, Balsamo A. Breschi MC, et al. J Med Chem. 2008 Nov 13;51(21):6945-54. doi: 10.1021/jm800956g. Epub 2008 Oct 17. J Med Chem. 2008. PMID: 18925735

5

NO-glibenclamide derivatives: prototypes of a new class of nitric oxide-releasing anti-diabetic drugs.

Calderone V, Rapposelli S, Martelli A, Digiacomo M, Testai L, Torri S, Marchetti P, Breschi MC, Balsamo A. Calderone V, et al. Among authors: breschi mc. Bioorg Med Chem. 2009 Aug 1;17(15):5426-32. doi: 10.1016/j.bmc.2009.06.049. Epub 2009 Jun 27. Bioorg Med Chem. 2009. PMID: 19595600

6

Anti-ischemic properties of a new spiro-cyclic benzopyran activator of the cardiac mito-KATP channel.

Calderone V, Testai L, Martelli A, Rapposelli S, Digiacomo M, Balsamo A, Breschi MC. Calderone V, et al. Among authors: breschi mc. Biochem Pharmacol. 2010 Jan 1;79(1):39-47. doi: 10.1016/j.bcp.2009.07.017. Epub 2009 Aug 4. Biochem Pharmacol. 2010. PMID: 19660436

7

Synthesis and evaluation of multi-functional NO-donor/insulin-secretagogue derivatives for the treatment of type II diabetes and its cardiovascular complications.

Digiacomo M, Martelli A, Testai L, Lapucci A, Breschi MC, Calderone V, Rapposelli S. Digiacomo M, et al. Among authors: breschi mc. Bioorg Med Chem. 2015 Feb 1;23(3):422-8. doi: 10.1016/j.bmc.2014.12.043. Epub 2014 Dec 26. Bioorg Med Chem. 2015. PMID: 25577707

8

Pathophysiological Role of Mitochondrial Potassium Channels and their Modulation by Drugs.

Citi V, Calderone V, Martelli A, Breschi MC, Testai L. Citi V, et al. Among authors: breschi mc. Curr Med Chem. 2018;25(23):2661-2674. doi: 10.2174/0929867324666171012115300. Curr Med Chem. 2018. PMID: 29022502 Review.

9

The Renal Outer Medullary Potassium Channel (ROMK): An Intriguing Pharmacological Target for an Innovative Class of Diuretic Drugs.

Calderone V, Martelli A, Piragine E, Citi V, Testai L, Breschi MC. Calderone V, et al. Among authors: breschi mc. Curr Med Chem. 2018;25(23):2627-2636. doi: 10.2174/0929867324666171012120937. Curr Med Chem. 2018. PMID: 29022503 Review.

10

Synthesis and biological evaluation of 5-membered spiro heterocycle-benzopyran derivatives against myocardial ischemia.

Rapposelli S, Breschi MC, Calderone V, Digiacomo M, Martelli A, Testai L, Vanni M, Balsamo A. Rapposelli S, et al. Among authors: breschi mc. Eur J Med Chem. 2011 Mar;46(3):966-73. doi: 10.1016/j.ejmech.2011.01.003. Epub 2011 Jan 13. Eur J Med Chem. 2011. PMID: 21288603

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

139 results

Search Page

Filters